Status:
UNKNOWN
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Royal Brompton & Harefield NHS Foundation Trust
Chelsea and Westminster NHS Foundation Trust
Conditions:
COVID-19
SARS-CoV 2
Eligibility:
All Genders
16+ years
Brief Summary
DESIGN Longitudinal prospective observational multicentre study. Primary objective: Understand the immune mechanisms driving COVID-19 disease in patients with a history of lung disease
Detailed Description
INTRODUCTION 1.1 BACKGROUND Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is a new rapidly spreading infectious disease with no proven treatment options. The virus causes a spec...
Eligibility Criteria
Inclusion
- All patients ≥16 years old with confirmation of COVID-19
- All patients ≥ 16 years old with chronic lung disease (CF, non-CF bronchiectasis, asthma, COPD or Idiopathic Pulmonary Fibrosis) or with no evidence of prior chronic lung disease
- Healthy volunteers
Exclusion
- None
Key Trial Info
Start Date :
June 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04444609
Start Date
June 18 2020
End Date
June 1 2023
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton & Harefileld NHS Trusts
London, United Kingdom, SW3 6PP